Omics! Omics!

A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery

Sunday, February 25, 2018

PromethION: Straining at the Starting Gate

›
Due to the usual time conflicts, I've only watched bits-and-pieces of the Winter Olympics from South Korea. Which is unfortunate, as I d...
9 comments:
Sunday, February 18, 2018

AGBT: It Ain't Over 'til the Tattoo Wears Off

›
AGBT officially ended on Thursday night with a space-themed party, but I have a bunch of notes from interviews with company representatives ...
Wednesday, February 14, 2018

AGBT: BioNano Launches New Labeling Approach

›
AS AGBT opened, optical mapping company BioNano Genomics announced a new scheme for labeling genomic DNA inputs which substantially improve...
1 comment:

AGBT: Twist Biosciences Launches Sequence Capture Product

›
Twist Biosciences today launched a new product into the sequence capture space.  CEO Emily Leproust was presenting to the Gold Sponsor work...
Tuesday, February 13, 2018

AGBT: 10X Previews Three New Single Cell Applications

›
I spent breakfast with 10X Genomic's Michael Schnall-Levin and two of his 10X colleagues gave me a sneak peak at three new single cell p...
Monday, February 12, 2018

AGBT Swag Bag

›
Today at AGBT is light on the science talks; the afternoon is free for lazing around the resort complex -- or for swimming laps in the lazy...

AGBT 2018: It's Great to Be Back

›
All sorts of scheduling snafus have kept me away the past three years. So this time around, I vowed to go and made sure my calendar staye...
Saturday, February 10, 2018

Brown Webcast Note: Corrections and Expansions

›
After I post something, there's almost always something I realize I left out.  In my piece on Clive Brown's webcast of ONT improvem...
6 comments:
Friday, February 09, 2018

February 2018 Clive Brown Webcast Notes

›
Clive Brown's webcasts are always entertaining, and even the 6am Eastern Time start for Thursday's didn't hinder that aspect -- ...
6 comments:
Wednesday, February 07, 2018

Oxford Nanopore Outlook 2018

›
I'm behind on these posts.  My usual foibles were largely responsible for a while, but then I had the major (and sad) family issue that...
2 comments:
Tuesday, January 30, 2018

Fingerprints on Jupiter

›
I had hoped to mark my father's 93rd birthday today in my usual way, a call home to exchange well wishes and update him on our goings-on...
6 comments:
Wednesday, January 17, 2018

PacBio Outlook 2018

›
Well, I didn't exactly get my Pacific Biosciences preview out before their J.P. Morgan presentation .  Luckily, the slides for that prim...
5 comments:
Tuesday, January 09, 2018

iSeq!

›
Illumina CEO Francis deSouza's J.P. Morgan Presentation did not disappoint.  While humdrum financials and touting market dominance and a...
3 comments:
Sunday, January 07, 2018

Illumina Outlook II: The Fleet

›
In my prior installment I looked at Firefly, now clearly a working instrument.  Now I'll take a peak at the rest of the Illumina fleet. ...
1 comment:
Tuesday, January 02, 2018

Illumina 2018 Preview I: Firefly

›
Time to start gazing into my cloudy liquid crystal ball and attempt to see what will happen in the sequencing world in 2018.  J.P. Morgan is...
Monday, January 01, 2018

Remembering 2017's Losses

›
A new year beckons and with it a burst of enthusiasm for writing.  Which also means combing through post ideas from last year that never qui...
2 comments:
Sunday, December 10, 2017

2017 Nanopore Community Meeting: An Incomplete Summary

›
The 2017 Nanopore Community Meeting was over a week ago back in New York City, so I'm grossly overdue in cobbling together some observat...
3 comments:
Thursday, December 07, 2017

On the Problem of Sequence Leakage

›
I've been spending some time lately in an unfamiliar world: the eukaryotic section of NCBI's NR protein database.  I've been alm...
2 comments:
Sunday, December 03, 2017

SmidgION: Mac Classic for the 21st Century?

›
Apple launched the Macintosh computer with a famous television ad playing on the launch year, 1984. What emerged was what we now know as the...
3 comments:
Monday, November 06, 2017

A Nucleotide Mixture-Based Error Correcting Short Read Chemistry

›
Sometimes polony-style short read sequencing seems like old news.  The underlying technology has been commercially available for over a deca...
2 comments:
‹
›
Home
View web version

About Me

My photo
Keith Robison
Dr. Robison spent 10 years at Millennium Pharmaceuticals working with various genomics & proteomics technologies & working on multiple teams attempting to apply these throughout the drug discovery process. He spent 2 years at Codon Devices working on a variety of protein & metabolic engineering projects as well as monitoring a high-throughput gene synthesis facility. After a brief bit of consulting, he rejoined the cancer drug discovery field at Infinity Pharmaceuticals in May 2009. In September 2011 he joined Warp Drive Bio, a startup applying genomics to natural product drug discovery. In February 2019 he joined Ginkgo Bioworks, a synthetic biology company. Other recurring characters in this blog are his late loyal Shih Tzu Amanda, his current Shih Poo Lily and his now adult son alias TNG (The Next Generation). Dr. Robison can be reached via his Gmail account, keith.e.robison@gmail.com You can also follow him on Twitter as @OmicsOmicsBlog.
View my complete profile
Powered by Blogger.